CD8A and neoplasm: In other solid tumor models, miR-182 released from huMSCs-exos killed clear cell renal cell carcinoma (ccRCC) by suppressing VEGFA expression promoting increased numbers of DCs, NKT cells and CD8 + T cells as well as enhancing the sensitivity of tumor cells to NKT cells [611].